Metraipolis › archive › dc_98c24dffb92b
High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors — Europe PMC PMID:41531972
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41531972
- DOI
- 10.1021/acsmedchemlett.5c00528
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:53:16.002Z
- SHA-256 of the archived text
20ecba97e41ce8abd892f008791beddbcdf9c2648a0d3bea40b0e2a950b0f824- Stable URL of this page
https://metraipolis.com/documento/dc_98c24dffb92b
How to cite
High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors — Europe PMC PMID:41531972 — Europe PMC (en), https://europepmc.org/article/MED/41531972 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98c24dffb92b (Metraipolis archive dc_98c24dffb92b, sha256 20ecba97e41ce8abd892f008791beddbcdf9c2648a0d3bea40b0e2a950b0f824)
BibTeX
@misc{dc98c24dffb92b,
title = {High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors — Europe PMC PMID:41531972},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41531972},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98c24dffb92b; sha256 20ecba97e41ce8abd892f008791beddbcdf9c2648a0d3bea40b0e2a950b0f824},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41531972. Agents can read the archived copy with the MCP tool read_document.